mortality/aging
• in some tamoxifen-treated mice (mean survival 592 days)
• mice treated with caffeine and tamoxifen do not survive beyond 100 days (mean survival 62 days)
|
immune system
• severe in mice treated with caffeine and tamoxifen
|
• after 7 months of tamoxifen treatment, all mice exhibit myeloproliferative disease in the bone marrow and spleen
• tamoxifen-treated mice exhibit myeloid hyperproliferation followed by induction of cellular senescence more robustly in the bone marrow than spleen
|
neoplasm
• caffeine treatment facilitates acute myeloid leukemia development in tamoxifen-treated mice
• caffeine treatment of tamoxifen-treated mice promotes acquisition of self-renewal capacity and enables development of leukemia stem cells
|
liver/biliary system
• severe in mice treated with caffeine and tamoxifen
|
hematopoietic system
• severe in mice treated with caffeine and tamoxifen
|
• after 7 months of tamoxifen treatment, all mice exhibit myeloproliferative disease in the bone marrow and spleen
• tamoxifen-treated mice exhibit myeloid hyperproliferation followed by induction of cellular senescence more robustly in the bone marrow than spleen
|
growth/size/body
• severe in mice treated with caffeine and tamoxifen
|
• severe in mice treated with caffeine and tamoxifen
|